13F-HR filed by Privium Fund Management B.V.
Privium Fund Management B.V. filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-07-30, with 55 holding rows worth $463,503,750.
- Accession
- 0001754960-25-000506
- Filer
- CIK 1795097
- Filed
- 2025-07-30
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 55 entries on the cover page, a total value of $463,503,750 stated on the cover page (in dollars after the unit check, H1), rows summing to $463,503,750 with VALUE read as dollars as filed, 13F file number 028-21695. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPOTIFYTECHNOLOGYSAF | L8681T102 | STOK | 114,000 | $84,822,350 | dollars as filed | |
| Tesla Motors, Inc | 88160R101 | COM | 242,000 | $74,670,220 | dollars as filed | |
| SHOPIFY INC | 82509L107 | CL A SUB VTG SHS | 430,000 | $48,970,700 | dollars as filed | |
| Palantir Technologies Inc. Class A | 69608A108 | COM | 350,000 | $46,584,000 | dollars as filed | |
| Amazon.com, Inc | 023135106 | COM | 149,000 | $32,771,500 | dollars as filed | |
| SEA LTD | 81141R100 | SPONSORD ADS | 210,000 | $32,501,800 | dollars as filed | |
| COINBASE GLOBAL INC COM CL A | 19260Q107 | Stock | 70,000 | $24,185,620 | dollars as filed | |
| NVIDIA Corp | 67066G104 | COM | 81,000 | $12,529,860 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 267,594 | $10,687,705 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 4,997,562 | $10,045,100 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 612,214 | $9,850,523 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 253,304 | $9,184,804 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 447,486 | $6,260,329 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 52,732 | $5,429,814 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 59,093 | $4,834,398 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 344,472 | $4,736,490 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 132,189 | $4,649,087 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 8,300 | $3,752,928 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 148,400 | $3,169,824 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 103,433 | $2,967,493 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 20,500 | $2,666,435 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 44,700 | $2,168,397 | dollars as filed | |
| AMBEV SA SPONSORED ADR | 02319V103 | ADR | 795,786 | $1,925,802 | dollars as filed | |
| CARVANA CO CL A | 146869102 | Stock | 5,000 | $1,684,800 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 107,622 | $1,401,238 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 126,923 | $1,388,538 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 46,000 | $1,309,160 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 9,320 | $1,295,573 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 10,987 | $1,181,212 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 432,760 | $1,120,848 | dollars as filed | |
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 22,000 | $1,096,700 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 163,000 | $1,056,240 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 37,029 | $927,206 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 135,550 | $883,786 | dollars as filed | |
| PAN AMERN SILVER CORP | 697900108 | COM | 29,747 | $844,815 | dollars as filed | |
| NOV INC | 62955J103 | COM | 63,876 | $825,278 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 197,458 | $819,451 | dollars as filed | |
| SPROTT FDS TR | 85208P303 | URANI MINER ETF | 16,278 | $761,159 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 178,356 | $752,662 | dollars as filed | |
| VIZSLA SILVER CORP | 92859G608 | COM NEW | 250,790 | $732,307 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 39,400 | $697,774 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 294,142 | $673,585 | dollars as filed | |
| SEABRIDGE GOLD INC | 811916105 | COM *D* | 44,074 | $648,329 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 119,000 | $610,470 | dollars as filed | |
| VALARIS LTD | G9460G101 | CL A | 13,803 | $605,952 | dollars as filed | |
| EMX RTY CORP | 26873J107 | COM | 216,968 | $544,590 | dollars as filed | |
| SANDRIDGE ENERGY INC | 80007P869 | COM NEW | 37,022 | $400,948 | dollars as filed | |
| NOBLE CORP PLC ORD SHS A | G65431127 | Stock | 14,287 | $392,035 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 134,900 | $315,666 | dollars as filed | |
| TIDEWATER INC NEW COM | 88642R109 | Stock | 5,350 | $255,195 | dollars as filed | |
| SIBANYE STILLWATER LTD SPONSORED ADR | 82575P107 | ADR | 34,040 | $247,811 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 27,566 | $239,273 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 509,059 | $220,575 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 111,090 | $126,643 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 25,241 | $78,752 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001754960-25-000506 | this filing | 2025-07-30 | acceptance time not in the bulk data set |